相关实验视频

Updated: Jul 5, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

青果实 (Aurantii fructus immaturus carbonisata) 衍生的碳点及其抗抑郁作用

Xiaopeng Li¹, Ertong Dai², Menghan Li¹

¹School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Frontiers in molecular biosciences

|January 23, 2024

概括

来自Aurantii Fructus Immaturus Carbonisata (AFIC-CDs) 的碳点显示出显著的抗抑郁作用. 这些化合物有效地减少了抑郁行为,并在临床前模型中调节了关键的神经递质,为抑郁症治疗提供了有前途的新途径.

科学领域:

药理学和毒理学药理学和毒理学
神经科学是一个神经科学.
材料科学材料科学材料科学

背景情况:

抑郁症是全球普遍存在的精神健康障碍,目前治疗效果有限,副作用有限.
传统中国医学使用Aurantii Fructus Immaturus (AFI) 治疗抑郁症,促使对其生物活性化合物的研究.
碳点 (CD) 是新兴的纳米材料,具有潜在的治疗应用.

研究的目的:

为了研究来自AFI Carbonisata (AFIC-CDs) 的碳点的抗抑郁性质.
使用临床前模型阐明AFIC-CDs抗抑郁作用的潜在机制.

主要方法:

AFIC-CD被提取,分离,并根据它们的结构和化学组进行了表征.
用慢性不可预测的轻度压力 (CUMS) 和储诱导的疼痛抑郁双小鼠模型来评估抗抑郁药的活性.
评估了行为测试 (不运动时间),神经递质水平 (血清素,多巴胺,上腺素),炎症标志物 (IL-1β,TNF-α) 和基因表达 (BDNF,Tph2).

主要成果:

在CUMS和疼痛抑郁模型中,AFIC-CD具有2-10纳米直径和丰富的化学组的特征,显著减少了不运动时间.
使用AFIC-CDs的治疗增加了大脑皮层中的血清素,多巴胺和北上腺素水平.
AFIC-CDs调节炎性细胞因子 (降低IL-1β和TNF-α),并增强了BDNF和Tph2mRNA的表达.

结论:

AFIC-CDs表现出显著的抗抑郁药活性,显示出作为抑郁症新型治疗剂的潜力.
这些发现表明,AFIC-CD通过调节神经递质系统,减少神经炎症和促进神经变因子来发挥其作用.
这项研究扩大了对碳点生物活动的理解,并为抑郁症管理提供了一个有希望的新策略.

关键词:

青的果实是不成熟的.碳点是指碳点的部分.抑郁抑郁症抑郁症抑郁症是一种纳米材料是一种纳米材料.传统的中医药是传统的中医药.

更多相关视频

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice

Published on: January 7, 2019

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...